-
[文献書誌] Taguchi, F., Nishio K., et al.: "hnRNP L enhances sensitivity of the cells to KW-2189"Int.J.Cancer. 108. 679-685 (2004)
-
[文献書誌] Koizumi, F., Nishio, K., et al.: "Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (IRESSA') and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells."Int.J.Cancer. 108. 464-472 (2004)
-
[文献書誌] Nishiyama, N., Nishio, K., et al.: "Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in Mice."Cancer Res.. 63. 8977-8983 (2003)
-
[文献書誌] Suzuki, T., Nishio, K., et al.: "MRP5b/SMRP mRNA is highly expressed in metallothionein-deficient mouse liver."J.Health Sci.. 49. 524-526 (2003)
-
[文献書誌] Tsunoda, T., Nishio, K., et al.: "Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis."Int.J.Oncol.. 23. 49-59 (2003)
-
[文献書誌] Usuda, J., Nishio, K., et al.: "Restoration of p53 gene function in 12-O-tetradecanoylphorbor 13-acetate-resistant human leukemia K562/TPA cells."Int.J.Oncol.. 22. 81-86 (2003)
-
[文献書誌] Saijo, N., Nishio, K., et al.: "Translational and clinical studies of target-based cancer therapy."Int.J.Clin.Oncol.. 8. 187-192 (2003)
-
[文献書誌] Kanzawa, F., Nishio, K., et al.: "In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other movel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell line."Lung Cancer. 40. 325-332 (2003)
-
[文献書誌] Nishiyama, N., Nishio, K., et al.: "Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles."Bioconjug.Chem.. 14. 449-457 (2003)
-
[文献書誌] Hirama, M., Nishio, K., et al.: "Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth."Cancer Lett.. 198. 107-117 (2003)
-
[文献書誌] Natsume, T., Nishio, K., et al.: "Antitumor activity of TZT-1027 (Soblidotin) against VEGF-secreting human lung cancer in vivo."Cancer Sci. 94. 826-833 (2003)
-
[文献書誌] Saijo, N., Nishio, K., et al.: "Strategy for the development of novel anticancer drugs."Cancer Chemother.Pharmacol.. 52. S97-S101 (2003)
-
[文献書誌] Yamanaka, R., Nishio, K., et al.: "Selection of surrogate marker genes in primary central nervous system lymphomas for radio-chemotherapy by DNA array analysis of gene expression profiles."Int.J.Oncol.. 23. 913-923 (2003)